We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Newborns Getting Preoperative Blood Transfusions Have More Complications

By LabMedica International staff writers
Posted on 05 Nov 2020
Print article
Image: A newborn baby’s foot with a peripheral intravenous catheter in the neonatal intensive care unit. Newborns undergoing surgery suffered worse outcomes if they had received preoperative blood transfusion (Photo courtesy of Atichayo).
Image: A newborn baby’s foot with a peripheral intravenous catheter in the neonatal intensive care unit. Newborns undergoing surgery suffered worse outcomes if they had received preoperative blood transfusion (Photo courtesy of Atichayo).
Blood transfusions in the neonatal patient population are common, but there are no established guidelines regarding transfusion thresholds. Little is known about postoperative outcomes in neonates who receive preoperative blood transfusions (PBTs).

Transfusion practices in neonatal intensive care units (ICUs) remain highly variable despite several randomized trials showing no harm with a restrictive transfusion strategy in babies compared with a liberal one. It's not uncommon for anemic newborns to receive transfusions prior to surgery as a precaution.

Medical scientists at the Alfred I. duPont Hospital for Children (Wilmington, DE, USA) and their colleagues identified a total of 12,184 neonates, of whom 1,209 (9.9%) received a PBT, all neonates who underwent surgery. Mortality and composite morbidity (defined as any postoperative complication) in neonates who received a PBT within 48 hours of surgery were compared with that in neonates who did not receive a transfusion.

The team reported that the incidence of 30-day mortality (16.8% versus 2.6%) and morbidity (46.2% versus 16.2%) put neonates who received blood transfusion within 48 hours of surgery at a disadvantage compared with peers not getting transfusion. Blood transfusion remained associated with worse postoperative outcomes after multivariable adjustment and propensity-score matching.

Specific postoperative complications that occurred more frequently in the transfusion group included infection, bleeding requiring transfusion, reintubation, reoperation, and hospital stay beyond 30 days. However, babies who did not receive transfusion had more readmissions within 30 days of surgery. There appeared to be a stronger relationship between mortality and morbidity and blood transfusion with rising preoperative hematocrit (up to 35%), though this finding did not reach statistical significance for interaction.

The authors concluded that it is likely that there is a tipping point or range in which the risks associated with anemia outweigh the risks associated with blood transfusion. For infants with significant anemia, it is plausible that the benefits of a blood transfusion, such as increased oxygen delivery, outweigh the associated risks (i.e., transfusion-related immunomodulation and a proinflammatory state), but as the anemia becomes less severe, the harm of a blood transfusion begins to outweigh the benefit. The study was published on October 1, 2020 in the journal Pediatrics.

Related Links:
Alfred I. duPont Hospital for Children

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A network of inflammatory molecules may act as biomarker for risk of future cerebrovascular disease (Photo courtesy of 123RF)

Simple Blood Test Could Enable First Quantitative Assessments for Future Cerebrovascular Disease

Cerebral small vessel disease is a common cause of stroke and cognitive decline, particularly in the elderly. Presently, assessing the risk for cerebral vascular diseases involves using a mix of diagnostic... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The ePlex system has been rebranded as the cobas eplex system (Photo courtesy of Roche)

Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases

GenMark Diagnostics (Carlsbad, CA, USA), a member of the Roche Group (Basel, Switzerland), has rebranded its ePlex® system as the cobas eplex system. This rebranding under the globally renowned cobas name... Read more

Pathology

view channel
Image: The Aperio GT 450 DX has received US FDA 510(k) clearance (Photo courtesy of Leica Biosystems)

Use of DICOM Images for Pathology Diagnostics Marks Significant Step towards Standardization

Digital pathology is rapidly becoming a key aspect of modern healthcare, transforming the practice of pathology as laboratories worldwide adopt this advanced technology. Digital pathology systems allow... Read more